Please login to the form below

Not currently logged in
Email:
Password:

EUSA Pharma appoints Rolf Hoffmann to its board

He most recently worked at Amgen for over a decade

Roff HoffmannOncology-focused pharmaceutical group EUSA Pharma has added to its board of directors in the form of Rolf Hoffman.

Hoffman, who is currently chairman of Biotest and sits on the board of directors of Genmab, brings over 30 years’ pharmaceutical experience to his new position having served in a number of senior roles in the industry.

He most recently spent 12 years with Amgen as its senior vice president of commercial operations, US and prior to that, he worked for SVP.

Hoffman said: “I have watched EUSA Pharma’s remarkable progress in the three years since it was founded, and am delighted to now help the company achieve its ambitious plans.”

His new role will see him play a role in guiding EUSA’s commercial strategy for its cancer treatments.

Bryan Morton, executive chairman at EUSA Pharma, said: “Rolf’s strategic insight and guidance, based on significant commercial experience in the oncology field will prove invaluable as EUSA launches Qarziba and Fotivda in Europe.”

8th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics